MedPath

The effect of radiation protection of oral atorvastatin in patients with breast cancer receiving radiotherapy

Phase 3
Recruiting
Conditions
Breast cancer & Radiotherapy.
Malignant neoplasm of breast
Registration Number
IRCT20181005041239N1
Lead Sponsor
Sari University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
100
Inclusion Criteria

Have the ability to read and write in farsi or be able to communicate if they are illiterate.
Women aged 18 and over
Women with breast cancer who receive radiation dosage during treatment with the standard technique of bilateral tangent 5000CG / 25F Photon.
Awareness of the person, time and place
The possibility of making direct telephone calls to a patient or an active member of his family (to follow the samples)
Based on bra / breast size =85
Women without known diseases and under medical treatmentSuch as diabetes, thyroid disorders, known liver disease, immune system weakness, rhabdomyolysis and cardiovascular disease, hyperlipidemia, depression and anxiety and taking statins with a doctor's order.
Not using a psychologist or psychiatrist's counsel at the time of the study or at least a month before the study begins.

Exclusion Criteria

Allergy to atorvastatin
Taking anti-inflammatory drugs
Addicted to alcohol, cigarettes and drugs

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath